Roquefort Therapeutics (LON:ROQ) Stock Price Up 10.2% – Here’s What Happened

Roquefort Therapeutics plc ( LON:ROQ – Get Free Report ) shares traded up 10.2% on Thursday . The company traded as high as GBX 5.

50 ($0.07) and last traded at GBX 4.47 ($0.



06). 1,300,436 shares were traded during trading, an increase of 117% from the average session volume of 599,877 shares. The stock had previously closed at GBX 4.

05 ($0.05). Roquefort Therapeutics Stock Performance The company has a current ratio of 0.

79, a quick ratio of 3.07 and a debt-to-equity ratio of 12.37.

The company has a market capitalization of £5.40 million, a PE ratio of -418.00 and a beta of 0.

05. The firm’s 50-day simple moving average is GBX 4.33 and its 200-day simple moving average is GBX 4.

14. About Roquefort Therapeutics ( Get Free Report ) Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.

See Also Receive News & Ratings for Roquefort Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roquefort Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter ..